Logotipo do repositório
 

Publicação:
Síndrome das pernas inquietas: Diagnóstico e tratamento. Opinião de especialistas Brasileiros

Página do item simplificado
dc.contributor.authorAloe, Flávio
dc.contributor.authorCardoso Alves, Rosana S.
dc.contributor.authorAndrade, Luiz Augusto Franco
dc.contributor.authorAssis, Márcia
dc.contributor.authorBacelar, Andrea
dc.contributor.authorBezerra, Márcio
dc.contributor.authorCardoso, Francisco
dc.contributor.authorFerraz, Henrique Ballalai
dc.contributor.authorFonseca, Ronaldo Guimarães [UNESP]
dc.contributor.authorHorta, Wagner
dc.contributor.authorHaddad, Mônica Santoro
dc.contributor.authorHasan, Rosa
dc.contributor.authorMattos, James Pitágoras de
dc.contributor.authorPrado, Gilmar
dc.contributor.authorRizzo, Geraldo
dc.contributor.authorRodrigues, Nonato
dc.contributor.authorSilva, Ademir Batista
dc.contributor.authorSilva, Delson José da
dc.contributor.authorTeive, Hélio Afonso Ghizoni
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionInstituto do Cérebro do Hospital Israelita Albert Einstein
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade Federal do Ceará (UFC)
dc.contributor.institutionUniversidade de Brasília (UnB)
dc.contributor.institutionUniversidade Federal de Goiás (UFG)
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)
dc.date.accessioned2014-05-27T11:22:34Z
dc.date.available2014-05-27T11:22:34Z
dc.date.issued2007-09-01
dc.description.abstractThis article contains the conclusions of the November 17-18, 2006 meeting of the Brazilian Study Group of Restless Legs Syndrome (GBE-SPI) about diagnosis and management of restless legs syndrome (RLS). RLS is characterized by abnormal sensations mostly but not exclusively in the legs which worsen in the evening and are improved by motion of the affected body part. Its diagnosis is solely based on clinical findings. Therapeutic agents with efficacy supported by Class I studies are dopamine agonists, levodopa and gabapentine. Class II studies support the use of slow release valproic acid, clonazepan and oxycodone. The GBE-SPI recommendations for management of SPI are sleep hygiene, withdrawal of medications capable of worsening the condition, treatment of comorbidities and pharmacological agents. The first choice agents are dopaminergic drugs, second choice are gabapentine or oxycodone, and the third choice are clonazepan or slow release valproic acid.en
dc.description.affiliationDepartamento de Neurologia Hospital Das Clínicas USP-SP
dc.description.affiliationServiço de Neurologia Infantil Departamento de Neurologia USP-SP
dc.description.affiliationInstituto do Cérebro do Hospital Israelita Albert Einstein, São Paulo
dc.description.affiliationDepartamento de Clínica Médica Setor de Neurologia Universidade Federal de Minas Gerais
dc.description.affiliationDepartamento de Neurologia Escola Paulista de Medicina UNIFESP
dc.description.affiliationDepartamento de Neurologia UNESP, Botucatu-SP
dc.description.affiliationSetor de Neurologia UFCE
dc.description.affiliationDepartamento de Neurologia UNB
dc.description.affiliationServiço de Neurologia Hospital Das Clínicas UFG
dc.description.affiliationDepartamento de Clínica Médica Setor de Neurologia UFPR
dc.description.affiliation, Avenida Pasteur 89 / 1107, 30150-290 Belo Horizonte MG
dc.description.affiliationUnespDepartamento de Neurologia UNESP, Botucatu-SP
dc.format.extent721-727
dc.identifierhttp://dx.doi.org/10.1590/S0004-282X2007000400035
dc.identifier.citationArquivos de Neuro-Psiquiatria, v. 65, n. 3 A, p. 721-727, 2007.
dc.identifier.doi10.1590/S0004-282X2007000400035
dc.identifier.file2-s2.0-34548858440.pdf
dc.identifier.issn0004-282X
dc.identifier.issn1678-4227
dc.identifier.scieloS0004-282X2007000400035
dc.identifier.scopus2-s2.0-34548858440
dc.identifier.urihttp://hdl.handle.net/11449/69841
dc.identifier.wosWOS:000249453900035
dc.language.isopor
dc.relation.ispartofArquivos de Neuro-Psiquiatria
dc.relation.ispartofjcr1.015
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectClonazepam
dc.subjectDopamine agonists
dc.subjectGabapentine
dc.subjectLevodopa
dc.subjectOxycodone
dc.subjectPeriodic leg movements
dc.subjectPramipexole
dc.subjectRestless legs syndrome
dc.subjectSleep
dc.subjectSlow release valproic acid
dc.subjectanticonvulsive agent
dc.subjectbenzodiazepine derivative
dc.subjectclonazepam
dc.subjectdopamine receptor stimulating agent
dc.subjectgabapentin
dc.subjectlevodopa
dc.subjectopiate
dc.subjectoxycodone
dc.subjectvalproic acid
dc.subjectabnormal sensation
dc.subjectakathisia
dc.subjectattention deficit disorder
dc.subjectBrazil
dc.subjectclinical practice
dc.subjectcontrolled study
dc.subjectdifferential diagnosis
dc.subjecthuman
dc.subjectperipheral neuropathy
dc.subjectrestless legs syndrome
dc.subjectsleep
dc.subjectslow drug release
dc.subjectAnticonvulsants
dc.subjectDiagnosis, Differential
dc.subjectDopamine Agents
dc.subjectDopamine Agonists
dc.subjectHumans
dc.subjectRestless Legs Syndrome
dc.titleSíndrome das pernas inquietas: Diagnóstico e tratamento. Opinião de especialistas Brasileirospt
dc.title.alternativeRestless legs syndrome: Diagnosis and treatment. Opinion of Brazilian expertsen
dc.typeArtigo
dcterms.licensehttp://www.scielo.br/revistas/anp/paboutj.htm
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentNeurologia, Psicologia e Psiquiatria - FMBpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
2-s2.0-34548858440.pdf
Tamanho:
164.48 KB
Formato:
Adobe Portable Document Format
Baixar

Coleções

Botucatu - FMB - Faculdade de Medicina